Опухоли женской репродуктивной системы (Sep 2014)

ANALYSIS OF THE RESULTS OF NEODJUVANT TREATMENT IN PATIENTS WITH CONSIDERATION FOR THE IMMUNOPHENOTYPICAL FEATURES OF BREAST CANCER

  • A. A. Subbotina,
  • V. P. Letyagin,
  • N. N. Tupitsyn,
  • I. V. Vysotskaya,
  • V. D. Yermilova

DOI
https://doi.org/10.17650/1994-4098-2008-0-4-31-34
Journal volume & issue
Vol. 0, no. 4
pp. 31 – 34

Abstract

Read online

The efficiency of neoadjuvant chemotherapy is directly related to the expression of CD95 (FAS/APO-1) apoptosis receptor on cancer cells, which is confirmed with the pathomorphism and changes of CD95-positive cells during neoadjuvant chemotherapy (the most effective CAF regimen is cyclophosphan, doxorubicin, and 5- fluorouracil).